A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment
Fig 14
Model predictions of the tumor volume vs. time for the control case (no treatment) as well as for treatment with 1 mg/kg TCZ administered every 7, 14, 21 and 28 days. The line shows the first day of the final dose for each treatment schedule.